incyte corp (INCY:NASDAQ GS)
Earnings & Estimates Summary - INCYTE CORP (INCY)
2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.
Quarterly Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Earnings
Incyte Corporation reported 2nd quarter 2014 losses of $0.22 per share on 08/2/2014.
Annual Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Annual Earnings
Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.
Quarterly Revenues - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Revenues
Incyte Corporation had 2nd quarter 2014 revenues of $99.6M USD. This missed the $128.9M USD consensus estimate of the 14 analysts following the company. This was -2.1% below the prior year's 2nd quarter results.
Annual Revenues - INCYTE CORP (INCY)
Incyte Corporation's Annual Revenues
Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.
|Alkermes PLC||$61.51 USD||-1.64|
|ARIAD Pharmaceuticals Inc||$9.13 USD||-0.76|
|BioMarin Pharmaceutical Inc||$132.30 USD||-0.88|
|Jazz Pharmaceuticals PLC||$170.37 USD||-2.45|
|Vertex Pharmaceuticals Inc||$132.35 USD||-1.70|
|View Industry Companies|